Intervention

microarray analysis

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 31 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials31

Recruiting1

Common conditions25

Lead sponsors shown15

Clinical trials

31 shown

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung CancerNCT00897117 · 2001-05-01

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28NCT01420185 · 2011-10-01

Panobinostat and Letrozole in Treating Patients With Metastatic Breast CancerNCT01105312 · 2010-09-01

Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202NCT00990873 · 2009-07-01

Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030NCT00899535 · 2008-10-01

Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 MutationsNCT00700778 · 2008-07-01

Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast CancerNCT00897845 · 2008-06-17

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialNCT00904514 · 2007-10-01

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung CancerNCT00897143 · 2007-06-01

DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast CancerNCT00899548 · 2007-01-01

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantNCT00900406 · 2007-01-01

Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or VermiculiteNCT00897247 · 2007-01-01

Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and FormoterolNCT00569712 · 2007-01-01

Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate CancerNCT00466752 · 2006-12-01

S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and FluorouracilNCT00897091 · 2006-07-01

Changes in DNA After Radiation Therapy in Patients With Prostate CancerNCT00899912 · 2006-06-01

Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17NCT00897065 · 2006-06-01

Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast CancerNCT00379509 · 2006-04-01

Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With ChemotherapyNCT00897299 · 2005-10-07

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast CancerNCT00463034 · 2005-04-01

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast CancerNCT00070278 · 2005-01-01

Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast CancerNCT00080860 · 2004-02-01

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast CancerNCT00898690 · 2003-03-01

Proteases in Patients With Prostate Cancer That Has Spread to the BoneNCT00899665 · 2001-07-01

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy ParticipantsNCT00899028 · 2001-05-01

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast CancerNCT00088829 · 2001-04-01

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast CancerNCT00017095 · 2001-03-01

Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryNCT00057798 · 2000-03-01

Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the BreastNCT00898937 · 1999-09-01

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45NCT00914043

Study of Biomarkers in Tissue Samples From Patients With Breast CancerNCT01004796

Common conditions

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

breast cancer19 lung cancer7 metastatic malignant neoplasm2 myelodysplastic syndrome2 precancerous condition2 prostate cancer2 anemia1 cancer1 gestational trophoblastic neoplasm1 graft versus host disease1 leukemia1 lymphoma1 malignant mesothelioma1 myelodysplastic/myeloproliferative neoplasm1 neuroblastoma1 ovarian cancer1 prostate adenocarcinoma1 testicular germ cell tumor1

Leading sponsors

Alliance for Clinical Trials in Oncology 3 Barbara Ann Karmanos Cancer Institute 2 Georgetown University 2 National Institutes of Health Clinical Center (CC) 2 NSABP Foundation Inc 2 Vanderbilt-Ingram Cancer Center 2 British Columbia Cancer Agency 1 Cambridge University Hospitals NHS Foundation Trust 1 Case Comprehensive Cancer Center 1 Eastern Cooperative Oncology Group 1 ECOG-ACRIN Cancer Research Group 1 European Organisation for Research and Treatment of Cancer - EORTC 1 Fox Chase Cancer Center 1 Massachusetts General Hospital 1 Radiation Therapy Oncology Group 1

Trial status mix

COMPLETED18

UNKNOWN6

TERMINATED4

WITHDRAWN2

RECRUITING1

Phase mix

PHASE24

PHASE13

NA2

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.